Peter G. Mack

I'll research this attorney's background and the tracked case.

The attorney appears to be deceased (2018), which explains the single tracked appearance. Let me verify the case and his notable work.

Let me check for notable Federal Circuit work and PTAB/post-grant activity.

Peter G. Mack — patent litigation summary

Focus and technology areas. Mack's practice centered on intellectual property litigation with a strong life-sciences and biotechnology component, alongside mechanical/electromechanical and industrial technology work. His tracked case, Incyte Genomics, Inc. v. Gene Logic, Inc. (N.D. Cal., No. 3:00-cv-04627, filed Aug. 2000), involved genomics database and gene-sequence patents. His wider docket of that era is dominated by industrial and instrumentation subject matter — e.g., Wall Colmonoy Corp. v. Hoganas AB (E.D. Mich. 2001, metallurgical/wear-resistant alloys), Beltpack Corp. v. Cattron Theimeg, Inc. (W.D. Pa. 2002, industrial remote-control equipment), and Canac Inc. litigation (E.D. Va. 2002, rail equipment). He also maintained an active trademark and general IP counseling practice, with hundreds of USPTO trademark filings from 1980–2002.

Side preference. The authoritative case list shows a single tracked appearance, on the plaintiff side, where he represented Incyte — a product company, not an NPE/PAE (Incyte is classified as a "product company" asserter in the Stanford NPE dataset). That single data point is too thin to establish a defense-side or NPE-prosecution orientation; other dockets from the same period list him for both patent owners and challengers (e.g., patent owner in Beltpack, challenger-side in the related Cattron Theimeg action), so the better reading is a mixed enforcement/defense practice rather than a specialist for either camp.

Firm context. Mack spent the bulk of his career at Foley & Lardner, where he was a senior partner and litigator in the Washington, D.C. office. Before that he founded Schwartz, Jeffery, Schwab, Mack, Blumenthal & Evans in 1978; that firm merged into Foley & Lardner in 1988. He retired from Foley as Partner Emeritus in 2007 and later practiced at the IP boutique Lee & Morse (USPTO registration data lists Lee & Morse as his firm). He died in September 2018, which explains the absence of recent filings — this is a historical practice profile. (Firm-history details come from a published obituary and aggregator profiles; they should be treated as secondary sourcing.)

Notable outcomes and PTAB experience. The most prominent tracked matter, Incyte v. Gene Logic, did not reach verdict: the parties settled in January 2001, with the suits dismissed by stipulation under a license agreement granting Gene Logic non-exclusive rights to the Incyte patents (reported in the Washington Post, Jan. 12, 2001, and reflected in the case docket and the parties' license agreement). No litigated verdict, Federal Circuit opinion, or ITC result for Mack could be reliably verified in the sources reviewed. He has no PTAB/IPR/PGR record — the PTAB was not created until 2012, four years after he left Foley and six years before his death; post-grant proceedings were simply not part of his practice era.

Bar and education. Admitted in Virginia (1973) and the District of Columbia (1993), and registered to practice before the USPTO; admitted before the U.S. Supreme Court (1980), the Federal Circuit (1982), the Fourth and Eleventh Circuits, and several district courts. Education: B.S., Marquette University (1968) and J.D., George Washington University (1972). Note that sources conflict on whether his undergraduate degree was in mechanical or biomedical engineering, so the discipline should not be stated with confidence.